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Heart Failure Switches RV Inotropic Responses from Negative to Positive
Guanying Wang, Che-Chung Yeh, Brian C. Jensen, Michael J. Mann,
Paul C. Simpson, Anthony J. Baker.
VA Medical Center, Univ Calif San Francisco, San Francisco, CA, USA.
Right ventricular (RV) failure is a common but poorly understood disease. It is
assumed that an understanding of RV failure can be extrapolated from studies
of the left ventricle (LV). Hypothesis: RV failure is similar physiologically to
LV failure.Methods: Using intact RV and LV trabeculae from nonfailing and
failing mouse hearts, we measured inotropic (force) responses to alpha-1 adren-
ergic receptor (a1-AR) stimulation, and assessed myofilament function using
skinned trabeculae. Results: Figure shows typical force records from electri-
cally paced trabeculae after a1-AR stimulation (arrows). For nonfailing RV tra-
beculae, force decreased 2753%, mean5SEM, n=9. In marked contrast, for
failing RV trabeculae, force increased 4956%, n=21. This switch in inotropic
response was paralleled by a switch in the myofilament response to a1-ARs
from decreased Ca2þ sensitivity (nonfailing) to increased Ca2þ sensitivity (fail-
ing). For LV trabeculae, inotropic and myofilament responses to a1-ARs were
not different in nonfailing versus failing hearts.Conclusions: In failing RV, the
inotropic response to a1-ARs is switched from negative to positive due to
a switch in the myofilament
response to a1-ARs from de-
creased to increased Ca2þ
sensitivity. Reject study hy-
pothesis, because RV failure
is different physiologically
from LV failure.
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In Vitro Motility Studies of C-terminal Myosin Regulatory Light Chain
Mutants Implicated in Familial Hypertrophic Cardiomyopathy
William M. Schmidt1, James Watt1, Katarzyna Kazmierczak2, Jeff Moore1,
Danuta Szczesna-Cordary2.
1Boston University School of Medicine, Boston, MA, USA, 2University of
Miami Miller School of Medicine, Miami, FL, USA.
Muscle thick filaments are primarily composed of the hexameric protein myo-
sin, which is responsible for the generation of force and motion. Myosin con-
sists of an N-terminal globular domain which, among other functions, binds to
the thin filament and an a-helical domain, which acts as a lever arm to transmit
force and motion. Familial hypertrophic cardiomyopathy (FHC), the leading
cause of sudden cardiac death among young people, is a pathological thicken-
ing of the ventricular walls of the heart that has been caused by single point mu-
tations in sarcomeric proteins, including the myosin regulatory light chain
(RLC). Based on our recent work with mutations in the N-terminus of the
RLC and the RLC location on the lever arm region, we hypothesized that the
RLC-FHC mutations in the C-terminus (P95A, K104E and D166V) may dis-
rupt force generation and contractility. To determine the effects of the FHC-
RLC mutations we generated beta isoform myosin bearing mutant light chains
by exchanging the porcine cardiac native light chain with recombinant mutant
light chains and examined the effects of the mutations with the in vitromotility
assay. Contrary to our hypothesis, none of the mutants exhibited changes in
force production using the frictional loading motility assay, and maximal fila-
ment velocity (Vmax) also remained unchanged. Next, we measured regulated
actin filament velocity as a function of calcium concentration. The velocity-
pCa dependence showed the expected sigmoidal characteristic for all tested
mutant myosins, however, the calcium sensitivity (pCa50) increased for
K104E and D166Vmutants. In addition, D166V and P95A exhibited higher co-
operativity. Data for D166V is consistent with previous studies performed in
skinned mouse papillary muscle fibers showing an increase in the calcium sen-
sitivity of force and ATPase (Kerrick et al., 2009, FASEB. J. 23:855-65).
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Single Molecule Kinetics in the Familial Hypertrophic Cardiomyopathy
RLC-R58Q Mutant Mouse Heart
Prasad Mettikolla1, Rafal Luchowski1, Shande Chen1,
Zygmunt Gryczynski1, Ignacy Gryczynski1, Danuta Szczesna-Cordary2,
Julian Borejdo1.
1UnivofNorthTexas,FortWorth,TX,USA, 2Univ ofMiami,Miami, FL, USA.
Familial hypertrophic cardiomyopathy (FHC) is caused by a single-point-muta-
tion in a gene that encodes for the ventricular myosin regulatory light chain
(RLC). FHC is a serious heart disease that often leads to a sudden cardiac death
of young athletes. Themutation is believed to alter the kinetics of interaction be-
tween actin and myosin causing heart to pump blood inefficiently. We reporthere the direct measurements of this kinetics. The measurements are based on
the fact that during contraction amyosin cross-bridge delivers periodic force im-
pulses to actin. Time average of those impulses is the isometric force, and an in-
dividual impulse carries the information about kinetics of the interaction. To be
able to extract this kinetic information, it is necessary to scale down the exper-
iments to the level of a single molecule. A single molecule of actin of transgenic
mouse hearts expressing R58Qmutation associated with a malignant phenotype
of FHCwas observed by sparse labeling with a fluorophore. The kinetic rate was
extracted from impulses by Fluorescence Correlation Spectroscopy (FCS). We
show that the kinetic rate is significantly larger in contracting cardiac myofibrils
of transgenic R58Q mice than of control transgenic wild type mice. We present
evidence that during contraction actin changed orientation at least two times,
suggesting that interaction with cross-bridges occurs in 2 or more steps.
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Contraction-Mediated Damage in mdx Mice Trabeculae: A Model for
Cardiomyopathy in Duchene Muscular Dystrophy
Ying Xu, Jill A. Rafael-Fortney, Paul M.L. Janssen.
The Ohio State University, Columbus, OH, USA.
Duchene muscular dystrophy (DMD) is an inherited and progressive disease of
striated muscle deterioration. Studies on skeletal muscle using an eccentric con-
traction model have provided great insight of the contraction-mediated damage
in skeletal muscle in DMD. Because of different contraction mechanics in the
cardiac vs. skeletal muscle, the protocols used to gain understanding in skeletal
muscle pathology cannot be readily applied to the myocardium. To investigate
contraction-mediated damage in dystrophin-deficient myocardium under phys-
iological conditions, we developed an in vitromodel of myocardial mechanics-
induced injury. We employed computer-programmed protocols to trigger con-
secutive lengthening ramps during the twitch contraction at 4 Hz in age
matched (young and adult)mdx and wild type mice right ventricular trabeculae.
These ultra-thin muscles possess all major cardiac cell types and their contrac-
tile behavior very closely mimics that of the whole heart. In the first group of
experiments, 10 lengthening contractions of various (1-10%) magnitude of
stretch were performed in trabeculae from 10 week old mdx and wild type
mice. In the second group, 100 lengthening contractions at each magnitude
were conducted in trabeculae from 20 weeks old mice. The peak isometric ac-
tive developed tension (Fdev, in mN/mm
2), diastolic tension (Fdia), and force ki-
netics were measured throughout the protocol, and the rate of decline of these
parameters can be taken as a relative measurement of how susceptible the myo-
cardium is to lengthening-induced dysfunction. Our results indicate dystrophin
deficient myocardium in oldermdxmice is more sensitive to severe mechanical
stress compared to age-matched wild type controls. This suggests that length-
ening contraction in myocardium is an appropriate model to study contraction-
mediated damage in DMD associated cardiomyopathy.
3722-Pos
Myofilament Force Development is Less Economic in Post-Infarct
Remodeled Myocardium
Jolanda van der Velden1, Nicky M. Boontje1, Daphne Merkus2,
Ger J.M. Stienen1, Dirk J. Duncker3.
1Institute for Cardiovascular Research VU University Medical Center,
Amsterdam, Netherlands, 2Experimental Cardiology; COEUR; Erasmus
Medical Center, Rotterdam, Netherlands, 3Experimental Cardiology;
COEUR; Erasmuc Medical Center, Rotterdam, Netherlands.
Mismatch between energy supply and demand may limit cardiac performance
of the remodeled heart after myocardial infarction. To assess whether economy
of myofilament contraction is altered in the post-infarct remodeled myocar-
dium, force and ATP utilization were measured simultaneously in permeabi-
lized muscle strips from pigs with a myocardial infarction (MI). Remote left
ventricular subendocardial muscle strips were taken 3 weeks after sham surgery
(n=5) or induction of MI (n=5), by ligation of the left circumflex coronary ar-
tery. Isometric force and ATP consumption were measured at various [Ca2þ] in
17 permeabilized muscle strips in each group.
Three weeks after infarction, significant LV remodeling had occurred, reflected
by LV dilation and hypertrophy of the surviving myocardium. LV systolic dys-
function was evident from the significantly reduced ejection fraction. Maximal
force was significantly lower in MI (1451 kN/m2) compared to sham (2952
kN/m2), while maximal ATPase activity was slightly, though not significantly
lower in MI (3355 mM/s) compared to sham (4555 mM/s). Tension cost, the
rate of ATP splitting divided by isometric force is a measure of muscle econ-
omy. Mean tension cost at maximal activation was almost two-times higher in
MI compared to sham (P<0.05). In addition, Ca2þ-sensitivity (pCa50) of force
and ATPase activity were significantly higher in post-MI remodeled myocar-
dium compared to sham. Moreover, Ca2þ-sensitivity of ATPase activity was
significantly higher than Ca2þ-sensitivity of force in MI myocardium
716a Wednesday, February 24, 2010(DpCa50=0.0850.02), while no significant difference was present in sham
hearts (DpCa50=0.0150.02).
These measurements indicate that economy of myofilament contraction is re-
duced in post-MI remodeled myocardium.
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Myosin Heavy Chain Isoform Expression and Contractile Function in
Mechanically Unloaded Left Ventricles Following Left Ventricular Assist
Device (LVAD) Implantation
Matthew R. Locher, Holly S. Norman, Satoru Osaki, Takushi Kohmoto,
Nancy K. Sweitzer, Richard L. Moss.
University of Wisconsin Madison, Madison, WI, USA.
The ventricles of human myocardium normally express low levels of a myosin
heavy chain (MHC) on a predominately bMHC background. However, in heart
failure the distribution changes to ~100% b MHC with virtually undetectable
levels of aMHC, a change that has been associatedwith contractile dysfunction.
In cases of severe failure, surgical implantation of a left ventricular assist device
(LVAD) may be used as destination therapy and has been previously associated
with improvements in contractile function in single myocytes. Here, we used
post-LVADmyocardium in which the heart has been explanted for transplanta-
tion to test the hypothesis that mechanical unloading of ventricular myocardium
increases contraction kinetics, possibly through the re-expression of a MHC.
Measurements of themaximal rate of ATP utilization and isometric force in per-
meabilizedmulticellular preparations revealed no significant difference between
failing myocardium prior to LVAD implantation (pre-LVAD) and post-LVAD
myocardium. Tension cost, which is calculated as the rate of ATP utilization di-
vided by the isometric force, was also similar between groups. For comparison,
normalmyocardiumdisplayedmaximal rates of ATP turnover that were approx-
imately 2.5-fold greater than in pre- and post-LVAD myocardium. SDS-PAGE
indicated virtually undetectable levels of aMHC in pre- and post-LVAD myo-
cardium, while protein phosphorylation gels revealed significant differences in
the basal level of phosphorylation of myosin binding protein-C, TnT, and TnI
between both groups. These results suggest that while mechanical unloading
of failing myocardiummay not cause a re-expression of aMHC, improvements
in contractile function following LVAD implantation may be associated in part
with alterations in the phosphorylation status of key regulatory proteins. This
work supported by NIH RO1-HL61635 (RLM).
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Myofibrillar Protein Expression and Contractility in Neonates and Infants
with Congenital Right Ventricular Outflow Obstruction
Fatiha Elhamine, Bodgan Iorga, Gerardus Bennink, Konrad Brockmeier,
Robert Stehle, Gabriele Pfitzer.
University of Cologne, Koeln, Germany.
In this study we investigated the postnatal developmental changes in sarcomeric
protein expression in parallel with contractile parameters in myofibrils isolated
from small resections from the right ventricular (RV) outflow tract in 25 patients
with Tetralogy of Fallot and related congenital heart diseases (CHD). These
CHDs are associated with RV hypertrophy and outflow tract obstruction. The
age of the patients ranged from 4 days to 38 months. The resections were pro-
cured during surgical correction of the cardiac malformation and would have
been otherwise discarded. In the neonate (4 days old), the expression of slow
skeletal TnI (ssTnI) and atrial light chain (ALC-1) was ~82% and ~50% respec-
tively and declined to respectively< ~8% and ~3% at the age of 38months. This
down-regulation in ssTnI and ALC-1 expression correlated (p<0.05) with the
decline in Ca2þ-sensitivity from pCa50 ¼ 5.95 in the neonate to pCa50 ¼ 5.33
in 38 months old infants. Neither contraction nor relaxation kinetics correlated
with ssTnI expression. However, ALC-1 expression correlated positively with
the activation kinetics, kACT and force redevelopment, kTR (r ¼ 0.62, p<0.05).
The time course of relaxation is biphasic with an initial slow quasi-linear decay
followed by a fast exponential decay. The rate constant of the fast exponential
decay, kREL correlated positively with ALC-1 expression (r ¼ 0.57, p<0.05).
In summary right ventricular hypertrophy associated with congenital heart dis-
ease does not prevent the developmental down-regulation of ssTnI and ALC-1
although we cannot exclude that this down-regulation occurs at a slower rate
than in healthy infants. The change in ssTnI expression correlates with the ex-
pected decrease in Ca2þ-sensitivity while ALC-1 expression appears to modu-
late crossbridge turnover kinetics in agreement with studies in animals.
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Sex Dimorphic Myofilament Function and AMPK Expression in R403Q
Hearts
John P. Konhilas.
University of Arizona, Tucson, AZ, USA.
Male mice expressing an autosomal dominant mutation in alpha-myosin heavy
chain (R403Q) develop hypertrophic cardiomyopathy characterized by pro-gressive left-ventricular dilation and cardiac dysfunction whereas females do
not. We wished to determine whether these sex dimorphisms were due to un-
derlying differences in myofilament contractile function. Therefore, we deter-
mined the sensitivity of the myofilaments to Ca2þ in demembranated cardiac
trabeculae (CT) from wild-type (WT) and R403Q male and female mice
(10-12 months of age). We demonstrate that the R403Q mutation did not affect
Ca2þ-sensitive tension development in CT from males. While Ca2þ-sensitivity
was greater in both male WT and R403Q CT compared to WT females, they
were less sensitive to Ca2þ than CT from female R403Q hearts. We also deter-
mined rates of tension redevelopment (ktr) following a release-restretch proto-
col in CT from WT and R403Q male and female hearts at the same age. CT
from R403Q male hearts exhibited an enhanced ktr compared to WT males.
The ktr in WT female CT was similar to WT males. The ktr in R403Q female
CT measured between WT and R403Q males. We hypothesized that the sex di-
morphisms in myofialment function reflect an increase in the energetic cost of
contraction when expressing the R403Q mutation. Therefore, we measured
levels of Adenosine monophosphate-activated kinase (AMPK), a central sensor
of the cellular energy state. Total AMPK protein levels were significantly in-
creased in 10-12 month male R403Q hearts compared to WT controls. Female
R403Q hearts showed the opposite: total AMPKa expression was lower com-
pared to WT controls. We conclude that (1) the increased Ca2þ-sensitivity may
provide sufficient contractile support in female R403Q hearts maintaining
a compensated state, and (2) the increased AMPK expression in male R403Q
hearts is indicative of an increased energetic demand caused by the mutation.
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Intralipid Protects Cardiac Function of Late Pregnant Mice against
Ischemia/Reperfusion Injury
Jingyuan Li, Andrea Ciobotaru, Soban Umar, Parisa Partownavid,
Siamak Rahman, Mansoureh Eghbali.
UCLA, Los angeles, CA, USA.
Female mouse hearts show better functional recovery after ischemia/reperfusion
(I/R) injury comparedwithmales.However, the vulnerability of isolated late preg-
nant (LP)hearts to I/R injury is unknown.Herewe investigated the susceptibility of
isolatedmouse hearts in LP andpostpartum(PP) to I/R injury. Isolated hearts (Lan-
gendorff) from femalemice in diestrus stage (NP), LP, one day PP (PP1) and 7 day
PP (PP7) were subjected to 20 minutes of global normothermic (37C) ischemia
followedby40minutes of reperfusion.Theheart functionwas recorded throughout
the experiments and infarct size was assessed by triphenyltetrazolium staining at
the end of reperfusion. Although the function was similar in all 4 groups before
ischemia, the functional recovery of LP hearts at the end of reperfusion was
significantly lower compared to NP hearts; the rate pressure product (RPP) was
reduced from 1292651479mmHg*beats/min in NP to 16145438mmHg*beats/
min in LP mice. Interestingly, the RPP recovered partially in PP1 to
47165584mmHg*beats/min and almost fully back to NP levels one week PP.
Consistent with the functional recovery findings, the infarct size was markedly
larger in LP (59.755.2%) compared with NP (15.250.8%). The infarct size
was restored partially in PP1 and fully back in PP7. Recently we have observed
that Intralipid can protect the malemouse heart against I/R injury. To test whether
Intralipid can improve the heart function in LPmice, 1% Intralipid was applied to
isolated LP hearts at the onset of reperfusion. Intralipid treatment significantly im-
proved the cardiac function of LP mice (RPP=1156551599mmHg*beats/min)
and reduced the infarct size (1751.1%) to similar values as in NP. In conclusion,
isolatedLP hearts have high vulnerability to I/R injury and postischemic treatment
with Intralipid can protect the heart against I/R injury.
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Intralipid Induces Cardioprotection against Ischemia-Reperfusion Injury
by Inhibiting the Mitochondrial Permeability Transition Pore Opening
Via the PI3K/AKT Pathway
Siamak Rahman, Jean Chrisostome Bopassa, Jingyuan Li, Soban Umar,
Andrea Ciobotaru, Parisa Partownavid, Mansoureh Eghbali.
UCLA, Los angeles, CA, USA.
Acute myocardial infarction is a major cause of mortality, and the best hope of
salvaging viable myocardium is by rapid cardiac reperfusion. A novel cardio-
protective drug which could be applied at the time of reperfusion after acute
infarction would be ideal. Here we tested the hypothesis that administration
of Intralipid at the onset of reperfusion protects the heart against ischemia re-
perfusion (I/R) injury. Isolated hearts (Langendorff) from male mice were sub-
jected to 20 minutes of global normothermic (37C) ischemia followed by 40
minutes of reperfusion with Krebs Henseleit buffer (CTRL) or with additional
1% Intralipid (ILP). Postischemic treatment with Intralipid significantly im-
proved the cardiac function; the rate pressure product (RPP) was increased
from 34325334mmHg*beats/min in CTRL to 1540551011mmHg*beats/
min in ILP. Consistent with the higher functional recovery in ILP, the infarct
